default author photo

Miski Abdi

University of California, San Diego (UCSD)

SCHOLARLY PAPERS

1

DOWNLOADS

82

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Reducing Alzheimer’s Disease Risk in Diabetes: Synergistic Effects of Metformin, GLP-1 Receptor Agonists, and SGLT2 Inhibitors

Number of pages: 22 Posted: 20 Sep 2025
University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), affiliation not provided to SSRN, University of California, San Diego (UCSD) and University of California, San Diego (UCSD)
Downloads 82 (809,932)

Abstract:

Loading...

Alzheimer's Disease, Type 2 Diabetes, Metformin, SGLT2 Inhibitors, GLP-1 Receptor Agonist, HbA1c